since beclamide ( beta-chlorpropionamide ) was reported to reduce the neuroleptic doses required , the combination haloperidol-beclamide was tested using a double-blind , placebo-controlled study in 23 inpatients with an acute schizophrenic psychosis .
C0040615
neuroleptic
C0018546
haloperidol